文献速递腹部泌尿生殖MR

直肠腺癌新辅助放化疗后再分期MRI:影像表现与潜在陷阱

Restaging MRI of Rectal Adenocarcinoma after Neoadjuvant Chemoradiotherapy: Imaging Findings and Potential Pitfalls.
PubMed 文献 · Radiographics · 2023-01-01

本文阐述直肠腺癌新辅助治疗的指征、治疗后预期MRI表现及肿瘤消退分级系统,并介绍盆腔侧壁淋巴结分区与受累标准;同时讨论直肠MRI的局限性及再分期中的解读陷阱,强调MRI在「观察等待」策略中对疗效评估三要素之一的作用。

要点

  • 新辅助治疗后约30%患者可达病理完全缓解,为「观察等待」非手术管理提供可能。
  • 「观察等待」候选者需直肠指检、内镜和直肠MRI三方面均无恶性证据。
  • 盆腔侧壁淋巴结清扫仅用于有影像学侧壁淋巴结受累证据的特定患者。

核心结论

  • 直肠MRI在新辅助治疗后再分期中指导患者管理,可避免不必要的手术并发症,但需认识其局限性和解读陷阱。

研究设计与样本

  • 综述,来自Radiographics(RSNA, 2023),讨论新辅助治疗指征、治疗后预期影像表现、MRI肿瘤消退分级系统及盆腔淋巴结分区与标准。

关键影像表现/征象

  • 描述了直肠腺癌新辅助治疗完成后的预期影像表现。
  • 概述了MRI肿瘤消退分级系统。
  • 回顾了盆腔相关淋巴引流分区。

诊断标准与关键数值

  • 「观察等待」候选者需直肠指检、内镜和直肠MRI三方面均无恶性证据。
  • 描述了用于判断局部区域淋巴结播散的淋巴结标准。
  • 盆腔侧壁淋巴结清扫仅用于有影像学侧壁淋巴结受累证据的特定患者。

临床应用与阅片要点

  • 直肠MRI可用于准确分期、影响新辅助治疗或直接手术的选择,并指导手术解剖层面。
  • 再分期时需注意新辅助治疗后的多种潜在解读陷阱,并了解如何避免。
  • 由于盆腔侧壁淋巴结清扫与永久性泌尿生殖功能障碍高风险相关,仅对特定有影像学侧壁淋巴结受累证据的患者进行。

局限性

  • 作者讨论了直肠MRI的局限性。
  • 作者描述了新辅助治疗后若干潜在解读陷阱。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Rectal adenocarcinoma constitutes about one-third of all colorectal adenocarcinoma cases. Rectal MRI has become mandatory for evaluation of patients newly diagnosed with rectal cancer because it can help accurately stage the disease, impact the choice to give neoadjuvant therapy or proceed with up-front surgery, and even direct surgical dissection planes. Better understanding of neoadjuvant chemoradiotherapy effects on rectal tumors and recognition that up to 30% of patients can have a pathologic complete response have opened the door for the nonsurgical "watch-and-wait" management approach for rectal adenocarcinoma. Candidates for this organ-preserving approach should have no evidence of malignancy on all three components of response assessment after neoadjuvant therapy (ie, digital rectal examination, endoscopy, and rectal MRI). Hence, rectal MRI again has a major role in directing patient management and possibly sparing patients from unnecessary surgical morbidity. In this article, the authors discuss the indications for neoadjuvant therapy in management of patients with rectal adenocarcinoma, describe expected imaging appearances of rectal adenocarcinoma after completion of neoadjuvant therapy, and outline the MRI tumor regression grading system. Since pelvic sidewall lymph node dissection is associated with a high risk of permanent genitourinary dysfunction, it is performed for only selected patients who have radiologic evidence of sidewall lymph node involvement. Therefore, the authors review the relevant lymphatic compartments of the pelvis and describe lymph node criteria for determining locoregional nodal spread. Finally, the authors discuss limitations of rectal MRI, describe several potential interpretation pitfalls after neoadjuvant therapy, and emphasize how these pitfalls may be avoided. © RSNA, 2023 Quiz questions for this article are available in the supplemental material.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Awiwi MO, Kaur H, Ernst R, et al. Restaging MRI of Rectal Adenocarcinoma after Neoadjuvant Chemoradiotherapy: Imaging Findings and Potential Pitfalls. Radiographics. 2023. PMID: 36927125. doi:10.1148/rg.220135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。